DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 4 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 54.6. According to RSI analysis, drreddy is at it's resistance. 2.0 DRREDDY RSI Chart
MACD (?) MACD: -6.02 and Signal Line: -14.8. According to MACD analysis, drreddy is marginally strong. 7.0 DRREDDY MACD Chart
Simple Moving Average (?) Price just got above it's 50-day simple moving average which is a positive signal. According to simple moving average analysis, drreddy is facing resistance from it's 200-day simple moving average at 2295.36 and support level is at 2.15e+03. 8.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, drreddy is facing resistance at 2.16e+03 and support level is at 2120.962. 3.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.835. According to bollinger bands, drreddy is technically strong. 7.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 38.2% level. Support is at 2133.0603. Resistance levels are 2158.625 and 2184.1897. 3.0 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 45 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 27.8 which means DRREDDY is in a trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 24, 2018
Open Price 2131.9
High Price 2180.0
Low Price 2127.05
Close Price 2150.15
Absolute Change 14.6
Percentage Change 0.684%
Weekly Change 2.12%
Monthly Change 3.76%
Yearly Change -17.5%
52-week high 2787.0
52-week low 1901.15
Corporate Actions
ExDate Purpose
July 17, 2017 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.498
Confidence in Beta1.24%
Market Capital Rs. 36677.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 27.2
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 24 April 2018: Deliverable Quantity:3.44e+05 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 24 April 2018: Daily Volatility:0.2254 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 24 April 2018: PCR_OI:0.415 PCR:0.18 NA DRREDDY PCR Chart
Option Pain (?) 24 April 2018: Max Pain:2150.0 NA DRREDDY Option Pain Chart
Premium (?) 24 April 2018 Premium: 4.6 Futures OI:2533000.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 24 April 2018: Price:2150.15 Put with maximum OI:2000.0 Call with maximum OI:2200.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
April 26, 2018 2154.75 2533000.0 8007.0 11897.0 2150.15
May 31, 2018 2165.1 2130500.0 3195.0 6543.0 2150.15
June 28, 2018 2178.0 5000.0 14.0 15.0 2150.15

Announcements

April 24, 2018 Dr.Updates. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.
April 19, 2018 Dr.Allotment of ESOP/ESPS. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 19089 Equity Shares under ESOP
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 03, 2018 January 25, 2018 inResultsnter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017.
October 06, 2017 October 31, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017.
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 2072 Rs. 2099 Rs. 2125 Rs. 2152 Rs. 2178 Rs. 2205 Rs. 2231